EU Wants Illumina To Unwind $8B Grail Deal 'Swiftly'
The European Union's antitrust enforcer on Monday outlined steps for Illumina to take as it unwinds its $8 billion reacquisition of cancer-testing outfit Grail, after the watchdog barred the deal over...To view the full article, register now.
Already a subscriber? Click here to view full article